The following is a news item reported by Reuters: |
WASHINGTON, Jan 29 (Reuters)—Wright Medical Group, a maker of reconstructive implants for knees and hips, on Tuesday filed to sell 3 million shares of common stock. |
In a filing with the U.S. Securities and Exchange Commission, it said it plans to use the proceeds from the offering for general corporate purposes, working capital, research and development, and acquisitions. |
After the sale there will be about 31.5 million shares outstanding in the Arlington, Tennessee-based company, according to the SEC filing. |
Wright shares closed at $17.15 on Nasdaq. |
The common stock of Wright Medical Group has a par of $.01 per share. |
Required: |
Prepare the journal entry to record the sale of the shares assuming the price existing when the announcement was made and ignoring share issue costs. (If no entry is required for a transaction/event, select "No journal entry required" in the first account field. Enter your answers in whole dollars.) |
General Journal | Debit | Credit | |
Cash | 51450000 | =3000000*17.15 | |
Common stock | 30000 | =3000000*0.01 | |
Paid-in capital—excess of par | 51420000 |
The following is a news item reported by Reuters: WASHINGTON, Jan 29 (Reuters)—Wright Medical Group, a...
The following is a news item reported by Reuters: WASHINGTON, Jan 29 (Reuters)-Knowlton Medical Group, a maker of reconstructive implants for knees and hips, on Tuesday filed to sell 3 million shares of common stock In a filing with the U.S. Securities and Exchange Commission, it said it plans to use the proceeds from the offering for general corporate purposes, working capital, research and development, and acquisitions After the sale there will be about 37.5 million shares outstanding in the...
The following is a news item reported by Reuters: WASHINGTON, Jan 29 (Reuters)-Knowlton Medical Group, a maker of reconstructive implants for knees and hips, on Tuesday filed to sell 3 million shares of common stock. In a filing with the U.S. Securities and Exchange Commission, it said it plans to use the proceeds from the offering for general corporate purposes, working capital, research and development, and acquisitions. After the sale there will be about 36.0 million shares outstanding in the...
The following is a news item reported by Reuters: WASHINGTON, Jan 29 (Reuters)-Knowlton Medical Group, a maker of reconstructive implants for knees and hips, on Tuesday filed to sell 3 million shares of common stock In a filing with the U.S. Securities dnd Exchange Commission, it said it plans to use the proceeds from the offering for general corporate purposes, working capital, research and development, and acquisitions After the sale there will be about 35 million shares outstanding in the...
The following is a news item reported by Reuters:WASHINGTON, Jan 29 (Reuters)— Orville Medical Group, a maker of reconstructive implants for knees and hips, on Tuesday filed to sell 4 million shares of common stock.In a filing with the U.S. Securities and Exchange Commission, it said it plans to use the proceeds from the offering for general corporate purposes, working capital, research and development, and acquisitions.After the sale there will be about 33.0 million shares outstanding in the Arlington, Tennessee-based...
5. Show the journal to record the declaration of cash dividends. The amount declared is $2,915 on the statement of equity. The amount actually paid on the cash flow statement is $2,905. Show journal entry here: Date Accounts Debit Credit Note-we will ignore the $1mil reduction in Retained Earnings on the Treasury Stock/other line. We aren't given enough information to re-create this journal entry. 7. We can move to the Treasury Stock Column next. We see that treasury stock was...